Literature DB >> 20352428

Th17 cells: positive or negative role in tumor?

Yuqiang Ji1, Wanggang Zhang.   

Abstract

Th17 cells have been recently identified as a distinct Th cell lineage and found in an experimental animal model of cancer and in human cancers, but whether these cells promote tumor growth or regulate antitumor responses remains controversial. This review provides a summary of the current literature regarding interleukin (IL)-17/IL-23 and Th17 cells in cancer and discusses their potential roles in cancer development. Finally, we note several issues in this research area that must be resolved before the design of novel therapeutic approaches specifically targeting Th17 cells in cancer become feasible.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352428     DOI: 10.1007/s00262-010-0849-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  40 in total

1.  Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells.

Authors:  Wanhong Ding; Michela Manni; Lori L Stohl; Xi K Zhou; John A Wagner; Richard D Granstein
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

Review 2.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

3.  Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer.

Authors:  Joseph D Phillips; Lawrence M Knab; Nichole R Blatner; Leila Haghi; Malcolm M DeCamp; Shari L Meyerson; Michael J Heiferman; Jeffrey R Heiferman; Fotini Gounari; David J Bentrem; Khashayarsha Khazaie
Journal:  Cancer Immunol Immunother       Date:  2015-06-06       Impact factor: 6.968

4.  Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study.

Authors:  Cristina Maccalli; Diana Giannarelli; Filippo Capocefalo; Lorenzo Pilla; Ester Fonsatti; Anna Maria Di Giacomo; Giorgio Parmiani; Michele Maio
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 5.  Dendritic cell-based vaccines: barriers and opportunities.

Authors:  Jessica A Cintolo; Jashodeep Datta; Sarah J Mathew; Brian J Czerniecki
Journal:  Future Oncol       Date:  2012-10       Impact factor: 3.404

Review 6.  T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.

Authors:  Jin Bian; Jianzhen Lin; Junyu Long; Xu Yang; Xiaobo Yang; Xin Lu; Xinting Sang; Haitao Zhao
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 7.  The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review.

Authors:  Simone Punt; Jessica M Langenhoff; H Putter; Gert Jan Fleuren; Arko Gorter; Ekaterina S Jordanova
Journal:  Oncoimmunology       Date:  2015-03-06       Impact factor: 8.110

8.  Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generation.

Authors:  Qunwei Wang; Hester A Franks; Joanne Porte; Mohamed El Refaee; Suharsh Shah; James Crooks; Poulam M Patel; Andrew M Jackson
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

9.  CpG oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells.

Authors:  Lin Xu; Chunhong Wang; Zhenke Wen; Ya Zhou; Zhongmin Liu; Yongjie Liang; Zengguang Xu; Tao Ren
Journal:  Clin Dev Immunol       Date:  2010-10-20

10.  CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.

Authors:  Chunyan Gu-Trantien; Sherene Loi; Soizic Garaud; Carole Equeter; Myriam Libin; Alexandre de Wind; Marie Ravoet; Hélène Le Buanec; Catherine Sibille; Germain Manfouo-Foutsop; Isabelle Veys; Benjamin Haibe-Kains; Sandeep K Singhal; Stefan Michiels; Françoise Rothé; Roberto Salgado; Hugues Duvillier; Michail Ignatiadis; Christine Desmedt; Dominique Bron; Denis Larsimont; Martine Piccart; Christos Sotiriou; Karen Willard-Gallo
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.